» Articles » PMID: 20804974

Regulation of the HIF-1alpha Level is Essential for Hematopoietic Stem Cells

Overview
Journal Cell Stem Cell
Publisher Cell Press
Specialty Cell Biology
Date 2010 Sep 1
PMID 20804974
Citations 475
Authors
Affiliations
Soon will be listed here.
Abstract

Hematopoietic stem cells (HSCs) are sustained in a specific microenvironment known as the stem cell niche. Mammalian HSCs are kept quiescent in the endosteal niche, a hypoxic zone of the bone marrow (BM). In this study, we show that normal HSCs maintain intracellular hypoxia and stabilize hypoxia-inducible factor-1alpha (HIF-1alpha) protein. In HIF-1alpha-deficient mice, the HSCs lost their cell cycle quiescence and HSC numbers decreased during various stress settings including bone marrow transplantation, myelosuppression, or aging, in a p16(Ink4a)/p19(Arf)-dependent manner. Overstabilization of HIF-1alpha by biallelic loss of an E3 ubiquitin ligase for HIF-1alpha (VHL) induced cell cycle quiescence in HSCs and their progenitors but resulted in an impairment in transplantation capacity. In contrast, monoallelic loss of VHL induced cell cycle quiescence and improved BM engraftment during bone marrow transplantation. These data indicate that HSCs maintain cell cycle quiescence through the precise regulation of HIF-1alpha levels.

Citing Articles

The role of different physical exercises as an anti-aging factor in different stem cells.

Xu J, Song Z Biogerontology. 2025; 26(2):63.

PMID: 40009244 DOI: 10.1007/s10522-025-10205-2.


Research progress of hypoxia-inducible factor-1α and zinc in the mechanism of diabetic kidney disease.

Qin W, Nie P, Hui X, Chen F, Hu X, Shi W Front Pharmacol. 2025; 16:1537749.

PMID: 39995420 PMC: 11847805. DOI: 10.3389/fphar.2025.1537749.


Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic Potential.

Kohutek Z, Caslin H, Fehrenbach D, Heimlich J, Brown J, Madhur M Circ Res. 2025; 136(3):325-353.

PMID: 39883790 PMC: 11790260. DOI: 10.1161/CIRCRESAHA.124.323778.


Significance of birth in the maintenance of quiescent neural stem cells.

Kawase K, Nakamura Y, Wolbeck L, Takemura S, Zaitsu K, Ando T Sci Adv. 2025; 11(4):eadn6377.

PMID: 39841848 PMC: 11753423. DOI: 10.1126/sciadv.adn6377.


Metabolic dysregulation in myelodysplastic neoplasm: impact on pathogenesis and potential therapeutic targets.

Zhou H, Xiang W, Zhou G, Rodrigues-Lima F, Guidez F, Wang L Med Oncol. 2024; 42(1):23.

PMID: 39644425 DOI: 10.1007/s12032-024-02575-3.